7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Medical Condition

Hemolytic Anemia

Hemolytic Anemia is a blood disorder where red blood cells are destroyed too early. Learn symptoms, causes, diagnosis and treatment options.

HematologyICD-10: D59.9
Overview — Hemolytic Anemia
Condition at a Glance
ICD-10 codeD59.9
SpecialtyHematology
Specialists18 doctors available

Quick answer

Hemolytic anemia is a condition in which red blood cells are destroyed faster than the body can replace them, reducing oxygen delivery and causing symptoms such as fatigue, weakness, jaundice, or shortness of breath. Treatment depends on the underlying cause and may include medicines, blood transfusion, management of related conditions, or in selected cases procedures such as spleen removal, guided…

What is hemolytic anemia?

Hemolytic anemia is a condition in which red blood cells are destroyed faster than the body can replace them. The medical word for this destruction is hemolysis. Red blood cells normally live for about 120 days, circulating through the bloodstream and carrying oxygen from the lungs to the rest of the body. In hemolytic anemia, these cells break down early — sometimes after only a few days or weeks — and the bone marrow, the spongy tissue inside bones that makes new blood cells, cannot always keep up with the loss. The result is anemia, which means the blood has too few healthy red blood cells to deliver enough oxygen to the body’s tissues.

When people ask what is hemolytic anemia, it helps to know that it is not a single disease but a group of related conditions with many possible causes. Some forms are inherited, meaning a person is born with a genetic change that affects the red blood cells themselves. Other forms are acquired, meaning they develop later in life because of an immune system problem, an infection, certain medications, or another underlying illness. Hemolytic anemia can affect people of any age, sex, or background. Inherited forms often appear in childhood or run in families, while acquired forms are more common in adults. The condition can range from mild and barely noticeable to severe and life-threatening, depending on how quickly red blood cells are being destroyed and how well the bone marrow compensates.

Symptoms of hemolytic anemia

Hemolytic anemia symptoms depend on how severe the anemia is, how quickly it developed, and the underlying cause. When red blood cell destruction happens slowly, the body often adapts, and symptoms may be mild or absent for a long time. When hemolysis happens suddenly — for example, in an acute immune reaction — symptoms can appear rapidly and feel dramatic.

Common symptoms include:

  • Fatigue and weakness — the most common complaint, caused by reduced oxygen delivery to muscles and organs.
  • Pale or yellowish skin — paleness (pallor) reflects fewer red blood cells; a yellow tint of the skin or the whites of the eyes (jaundice) occurs because red blood cell breakdown releases bilirubin, a yellow pigment.
  • Shortness of breath — especially with activity, as the body tries to compensate for low oxygen.
  • Rapid or irregular heartbeat — the heart pumps faster to move the reduced oxygen supply around the body.
  • Dark or tea-colored urine — a sign that hemoglobin, the oxygen-carrying protein inside red blood cells, is being released into the blood and filtered by the kidneys.
  • Dizziness or lightheadedness — particularly when standing up quickly.
  • An enlarged spleen or liver — the spleen, an organ that filters blood, may swell as it works to remove damaged red blood cells; this can cause a feeling of fullness or discomfort in the upper left abdomen.
  • Fever and chills — more common in sudden, acute episodes of hemolysis.

Symptoms can also differ by type. People with chronic inherited forms, such as hereditary spherocytosis or sickle cell disease, may have long-standing mild jaundice, gallstones (hardened deposits in the gallbladder, which can form when bilirubin levels are high over time), and episodes where symptoms worsen during infections. People with acquired autoimmune hemolytic anemia may notice a fairly rapid onset of fatigue, jaundice, and dark urine over days to weeks. In one uncommon subtype called cold agglutinin disease, symptoms such as bluish or painful fingers and toes may be triggered by cold temperatures. A very rapid drop in red blood cells can cause chest pain, confusion, or fainting, which are warning signs that need urgent medical attention.

Causes and risk factors

Hemolytic anemia causes fall into two broad groups: inherited (present from birth) and acquired (developing later in life).

Inherited causes

  • Sickle cell disease — a genetic condition in which red blood cells take on a rigid, crescent shape and break down early.
  • Thalassemia — a group of inherited disorders in which the body makes abnormal or reduced amounts of hemoglobin.
  • Hereditary spherocytosis and elliptocytosis — conditions in which the outer membrane of the red blood cell is fragile, so the cells are removed early by the spleen.
  • Enzyme deficiencies — most commonly glucose-6-phosphate dehydrogenase (G6PD) deficiency, in which red blood cells break down after exposure to certain triggers such as some medications, infections, or fava beans.

Acquired causes

  • Autoimmune hemolytic anemia — the immune system mistakenly makes antibodies (defense proteins) that attack the body’s own red blood cells. This can happen on its own or alongside other conditions such as lupus, certain lymphomas, or chronic lymphocytic leukemia.
  • Medications — certain antibiotics, anti-inflammatory drugs, and other medicines can, in some people, trigger immune-mediated red blood cell destruction.
  • Infections — malaria is a classic cause worldwide; some bacterial and viral infections can also trigger hemolysis.
  • Mechanical damage — artificial heart valves or certain small-vessel disorders can physically damage red blood cells as they circulate.
  • Transfusion reactions — receiving blood that is not correctly matched can cause rapid hemolysis; this is rare with modern blood-bank practices.
  • Other conditions — including rare disorders such as paroxysmal nocturnal hemoglobinuria, in which red blood cells lack a protective surface protein.

Risk factors include a family history of inherited blood disorders, certain ancestries in which specific genetic conditions are more common, autoimmune disease, some cancers of the blood or lymphatic system, recent infections, and exposure to medications known to trigger hemolysis in susceptible people. In many cases, especially with autoimmune forms, no clear trigger is ever found; doctors then call the condition idiopathic, meaning of unknown cause. The general ICD-10 code D59.9 refers to acquired hemolytic anemia when the specific cause has not been identified.

Diagnosis

Hemolytic anemia diagnosis begins with a medical history and physical examination. Your doctor may ask about family history of anemia or jaundice, recent infections, new medications, and how quickly symptoms appeared, and may examine you for pale skin, jaundice, and an enlarged spleen.

Blood tests are the foundation of the diagnosis. Commonly used tests include:

  • Complete blood count (CBC) — measures the number of red blood cells and the level of hemoglobin; in hemolytic anemia both are usually low.
  • Reticulocyte count — measures young, newly made red blood cells. A high count shows the bone marrow is working hard to replace destroyed cells, which is typical of hemolysis.
  • Peripheral blood smear — a laboratory technician or doctor examines the blood under a microscope. The shape of the red blood cells can point toward a specific cause, such as sphere-shaped cells in hereditary spherocytosis or fragmented cells in mechanical hemolysis.
  • Bilirubin — the yellow pigment released when red blood cells break down; the indirect (unconjugated) form is often elevated.
  • Lactate dehydrogenase (LDH) — an enzyme released from damaged cells; levels are typically high during hemolysis.
  • Haptoglobin — a blood protein that binds free hemoglobin; it is usually low or undetectable when red blood cells are being destroyed in the bloodstream.
  • Direct antiglobulin test (Coombs test) — detects antibodies attached to red blood cells. A positive result supports an autoimmune cause; a negative result points toward inherited or mechanical causes.

Depending on these initial results, doctors may order further tests, such as hemoglobin electrophoresis (which separates and identifies types of hemoglobin, useful for sickle cell disease and thalassemia), enzyme testing for G6PD deficiency, genetic testing for inherited membrane disorders, or specialized flow cytometry tests for rare conditions. Urine tests may detect hemoglobin or its breakdown products. Imaging such as an abdominal ultrasound may be used to check the size of the spleen and to look for gallstones. In some cases, particularly when a bone marrow problem or an underlying blood cancer is suspected, a bone marrow biopsy — taking a small sample of marrow, usually from the hip bone, for microscopic examination — may be recommended. Because the workup can be complex, diagnosis and ongoing care are usually coordinated by a hematologist, a doctor who specializes in blood disorders.

Treatment options for hemolytic anemia

Hemolytic anemia treatment depends on the cause, the severity of the anemia, and the person’s age and overall health. The main goals are to slow or stop the destruction of red blood cells, treat any underlying condition, and relieve symptoms. Care is typically managed within a hematology department, often together with other specialists when another disease is involved.

Watchful waiting and supportive care

Mild hemolytic anemia may not need immediate treatment. If symptoms are minimal and blood counts are stable, your doctor may recommend regular monitoring with blood tests, avoiding known triggers (for example, specific medications or foods in G6PD deficiency), and treating infections promptly. Supplements such as folic acid, a B vitamin the bone marrow uses to make new red blood cells, are often prescribed because the marrow’s increased activity raises the body’s demand for it.

Medications

For autoimmune hemolytic anemia, corticosteroids (anti-inflammatory medicines such as prednisone that calm the immune system) are usually the first-line treatment for the warm-antibody type. If steroids do not work or cannot be tapered without relapse, doctors may use other immune-modifying treatments, such as rituximab (an antibody medication that reduces the immune cells producing the harmful antibodies) or other immunosuppressant drugs. If a medication is thought to be causing the hemolysis, stopping that medication under medical supervision is usually the key step. When another disease — such as an infection, lupus, or a lymphoma — is driving the hemolysis, treating that underlying condition is central to controlling the anemia.

Blood transfusions

When anemia is severe or symptoms are significant, a transfusion of donor red blood cells can provide rapid but temporary relief. In autoimmune hemolytic anemia, finding fully compatible blood can be technically challenging, so transfusions are used carefully and matched as closely as possible. Transfusions treat the symptoms of anemia but do not stop the underlying destruction of red blood cells.

Procedures and surgery

Splenectomy — surgical removal of the spleen — may be considered for certain conditions, such as hereditary spherocytosis with significant symptoms or autoimmune hemolytic anemia that has not responded to medications. Because the spleen is a major site where damaged red blood cells are removed, taking it out can reduce hemolysis in selected patients. The spleen also helps fight certain infections, so people who have a splenectomy usually receive specific vaccinations beforehand and lifelong advice about infection risk. In some acute situations, plasma exchange (a procedure that filters certain components from the blood) may be used for specific rare causes. For severe inherited disorders such as sickle cell disease or thalassemia, options such as regular transfusion programs, iron-removal (chelation) therapy, and in carefully selected cases stem cell transplantation may be discussed by the treating team. Within Acibadem, these conditions are evaluated and managed by hematology specialists, with the treatment plan tailored to each patient’s diagnosis and overall health.

Living with hemolytic anemia and outlook

The outlook for hemolytic anemia varies widely and depends mainly on the cause. Many acquired forms — for example, those triggered by a medication or an infection — improve or resolve once the trigger is removed or treated. Autoimmune hemolytic anemia often responds to treatment, although some people experience relapses and need long-term follow-up or repeat courses of therapy. Inherited forms are lifelong conditions, but many people manage them well with regular monitoring, trigger avoidance, and treatment during flare-ups.

Day-to-day, people living with hemolytic anemia are usually advised to attend regular blood-test appointments, take prescribed medications and supplements consistently, report new symptoms such as worsening fatigue, jaundice, or dark urine promptly, and treat fevers and infections early, since infections can worsen hemolysis. Those with G6PD deficiency should keep an updated list of medications and foods to avoid. People who have had their spleen removed need to stay current with recommended vaccines and seek care quickly if they develop a fever. Pacing daily activities, eating a balanced diet, and staying hydrated can help with fatigue, though these measures support treatment rather than replace it. No doctor can promise a specific outcome, but with an accurate diagnosis and appropriate care, many people with hemolytic anemia lead full, active lives.

Frequently asked questions

What is hemolytic anemia in simple terms?

Hemolytic anemia means red blood cells are being destroyed faster than the bone marrow can replace them. Red blood cells carry oxygen, so when their numbers fall, the body’s tissues receive less oxygen, causing symptoms such as tiredness, paleness, shortness of breath, and sometimes yellowing of the skin and eyes. It can be inherited or develop later in life from immune problems, infections, medications, or other illnesses.

Can hemolytic anemia be cured?

It depends on the cause. Some acquired forms — such as those caused by a medication or an infection — often resolve once the trigger is removed or treated. Autoimmune forms can frequently be controlled with medication, and some people achieve long-lasting remission, though relapses are possible. Inherited forms generally cannot be cured with medication alone, but they can often be managed effectively, and in selected severe cases procedures such as splenectomy or stem cell transplantation may be considered. Your hematologist can explain what is realistic for your specific diagnosis.

How serious is hemolytic anemia?

Severity ranges from mild cases that need only monitoring to severe episodes that require hospital care and transfusions. A sudden, rapid drop in red blood cells can strain the heart and other organs and is treated as a medical emergency. Most cases fall between these extremes, and with proper diagnosis and treatment, the condition can usually be brought under control. Regular follow-up helps catch changes early.

What are the first signs of hemolytic anemia?

Early hemolytic anemia symptoms are often subtle: unusual tiredness, paler skin than usual, and feeling out of breath with activities that used to be easy. As hemolysis increases, jaundice (yellowing of the skin or eyes), dark or tea-colored urine, dizziness, and a rapid heartbeat may appear. Because these signs overlap with many other conditions, blood tests are needed to confirm the cause.

How do doctors confirm hemolytic anemia?

Hemolytic anemia diagnosis relies mainly on blood tests. Doctors typically look for a low hemoglobin level, a high reticulocyte count (showing the marrow is making new cells quickly), raised bilirubin and LDH, and low haptoglobin. A Coombs test checks whether the immune system is attacking the red blood cells, and a blood smear examined under the microscope can reveal cell shapes that point to specific causes. Additional genetic, enzyme, or bone marrow tests may follow depending on the initial results.

What triggers hemolytic anemia episodes?

Common triggers include infections, certain medications, and — in G6PD deficiency — specific drugs and fava beans. In cold agglutinin disease, exposure to cold temperatures can set off symptoms. In people with underlying autoimmune conditions or blood cancers, flare-ups of the underlying disease can worsen hemolysis. Identifying and avoiding personal triggers is an important part of long-term management.

How long does recovery from hemolytic anemia take?

There is no single timeline. When a trigger such as a medication is removed, blood counts often improve over weeks as the marrow replaces lost cells. Autoimmune forms may take weeks to months of treatment before counts stabilize, and some people need ongoing therapy. Inherited forms involve lifelong management rather than a one-time recovery. Your care team will track your blood counts to judge how well you are responding.

When to see a doctor

Make an appointment with a doctor if you notice persistent fatigue, unexplained paleness, yellowing of the skin or eyes, or dark urine, especially if these develop over days to weeks. If you have already been diagnosed with hemolytic anemia, contact your care team whenever symptoms worsen or new ones appear.

Seek urgent or emergency medical care if you experience any of the following red-flag signs:

  • Chest pain or pressure, or a racing or irregular heartbeat.
  • Severe shortness of breath, especially at rest.
  • Fainting, confusion, or extreme dizziness.
  • Rapidly worsening jaundice together with dark or red-brown urine.
  • High fever with chills, particularly if your spleen has been removed or you are on immune-suppressing medication.
  • Sudden severe pain in the upper left abdomen, which may signal a spleen problem.
  • Little or no urine output, which can indicate kidney strain from rapid hemolysis.

These signs can indicate a sudden, severe episode of red blood cell destruction, which requires prompt evaluation and treatment. Early medical attention gives doctors the best chance to identify the cause and stabilize your condition safely.

Add Acıbadem on Google

Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.

Share this page

Medically reviewed by the Acıbadem International Medical Board — September 2, 2026
See our medical review board →

Published: June 8, 2026Last updated: September 2, 2026
Update history
  • PublishedJune 8, 2026
  • Medical review approvedSeptember 2, 2026
  • Last content updateSeptember 2, 2026
Treatments

Treatments for This Condition

Departments

Care at Acibadem

Specialists

Doctors Who Treat This Condition

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.